AR081405A1 - Proceso para la preparacion de aminas olefinicas sustituidas con arilo o heteroarilo e intermediarios de las mismas - Google Patents

Proceso para la preparacion de aminas olefinicas sustituidas con arilo o heteroarilo e intermediarios de las mismas

Info

Publication number
AR081405A1
AR081405A1 ARP110101739A ARP110101739A AR081405A1 AR 081405 A1 AR081405 A1 AR 081405A1 AR P110101739 A ARP110101739 A AR P110101739A AR P110101739 A ARP110101739 A AR P110101739A AR 081405 A1 AR081405 A1 AR 081405A1
Authority
AR
Argentina
Prior art keywords
penten
methyl
amine
preparation
mol equivalent
Prior art date
Application number
ARP110101739A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR081405A1 publication Critical patent/AR081405A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D15/00—Lithium compounds
    • C01D15/06—Sulfates; Sulfites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/02—Crystallisation from solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/21—Monoamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal

Abstract

Un proceso mejorado para la preparacion de aminas olefínicas sustituidas con arilo tales como (2S)-(4E)-N-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina y (2S)-(4E)-N-metil-5-[3-(5-metoxipiridin)il]-4-penten-2-amina y a compuestos intermediarios utilizados en dicho proceso. Reivindicacinn 1: Un proceso para la preparacion de 4-penten-2-ol que comprende: agregar cloruro de vinilmagnesio a una mezcla de cloruro de cobre(l) y cloruro de litio, seguido por la adicion de oxido de propileno en un solvente adecuado. Reivindicacinn 4: Un proceso para la preparacion de N-(terc-butoxicarbonil)-N-metil-4-penten-2-amina que comprende: un proceso de acuerdo con la reivindicacion 3, seguido por: la adicion de 4-penten-2-ol a una solucion de 1,0 mol equivalente (en relacion con el oxido de propileno) de cloruro de p-toluenosulfonilo en tetrahidrofurano, la adicion del p-toluenosulfonato de 4-penten-2-ilo en solucion de tetrahidrofurano, a metilamina acuosa al 40%, la combinacion de la solucion resultante de N-metil-4-penten-2-amina con una mezcla de dicarbonato de di-terc-butilo en metil terc-butil éter, y la adicion de N,N-dimetiletanodiamina a la mezcla de reaccion de N-metil-4-penten-2-amina a N-(terc-butoxicarbonil)-N-metil-4-penten-2-amina. Reivindicacinn 5: Un proceso para la preparacion del ácido N-metil-4-penten-2-amina di- benzoil-L-(-)-tartárico que comprende: agregar una solucion de ácido (L)-(-)-benzoil-tartárico (0,5 mol equivalente en relacion con N-metil-4-penten-2-amina) a una solucion de N-metil-4-penten-2-amina en un solvente orgánico. Reivindicacinn 6: Un proceso para la preparacion de aminas olefínicas sustituidas con arilo tales como (2S)-(4E)-N-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina que comprende: a) mezclar (2S)-N-(terc-butoxicarbonil)-N-metil-4-penten-2-amina (1 mol equivalente) y 5-bromo-3-alcoxipiridina (1,1 mol equivalente) con una fuente de paladio (0,01 mol equivalente), un ligando de fosfina (0,24 mol equivalente) y una base (1,5 mol equivalente) en un solvente orgánico adecuado en una atmosfera de nitrogeno; b) agregar agua y calendar la mezcla hasta 90°C durante 15 a 25 horas o hasta que se haya logrado el nivel apropiado de conversion; c) enfriar la mezcla y agregar agua y un ácido, seguido de la agitacion a 0-70 °C durante 3 a 8 horas; d) separar el solvente orgánico y la fase acuosa ácida seguido del lavado de la fase acuosa con un solvente orgánico; e) ajustar el pH en la fase acuosa mediante la adicion de una base, y f) extraer el producto en la fase orgánica seguido por la separacion de la fase orgánica; y opcionalmente g) tratar la fase orgánica con un material de barrido de metales o carbon. Reivindicacinn 12: El compuesto de sal del ácido N-metil-4-penten-2-amina hemi-di-benzoil-L-(-)-tartárico.
ARP110101739A 2010-05-20 2011-05-20 Proceso para la preparacion de aminas olefinicas sustituidas con arilo o heteroarilo e intermediarios de las mismas AR081405A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34650410P 2010-05-20 2010-05-20

Publications (1)

Publication Number Publication Date
AR081405A1 true AR081405A1 (es) 2012-08-29

Family

ID=44991920

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101739A AR081405A1 (es) 2010-05-20 2011-05-20 Proceso para la preparacion de aminas olefinicas sustituidas con arilo o heteroarilo e intermediarios de las mismas

Country Status (15)

Country Link
US (1) US8703802B2 (es)
EP (1) EP2574188A4 (es)
JP (1) JP2013528601A (es)
KR (1) KR20130081221A (es)
CN (1) CN103180277A (es)
AR (1) AR081405A1 (es)
AU (1) AU2011256866B2 (es)
BR (1) BR112012029326A2 (es)
CA (1) CA2799650A1 (es)
IL (1) IL222940A0 (es)
MX (1) MX2012013193A (es)
RU (1) RU2012150449A (es)
SG (1) SG185497A1 (es)
TW (1) TW201213287A (es)
WO (1) WO2011146009A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108715573A (zh) * 2018-08-02 2018-10-30 江西力田维康科技有限公司 一种3-丁烯-1-醇的制备方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192946A (en) 1978-06-29 1980-03-11 Ciba-Geigy Corporation Process for producing 3-hydroxy-5-halopyridines
DE3148651A1 (de) 1981-12-09 1983-07-21 Henkel Kgaa "haarfaerbemittel, enthaltend 5-halo-2,3-pyridindiole als kupplerkomponente"
US4582823A (en) 1984-08-15 1986-04-15 Warner-Lambert Company Method for treating schizophrenia and medicaments therefor
WO1989000158A1 (en) 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
IT1226727B (it) 1988-07-29 1991-02-05 Simes Farmaci precursori della dopamina.
US4922901A (en) 1988-09-08 1990-05-08 R. J. Reynolds Tobacco Company Drug delivery articles utilizing electrical energy
EP0393781B1 (en) 1989-04-20 1995-02-08 ZAMBON GROUP S.p.A. Dopamine pro-drug
US5187166A (en) 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
WO1992012122A1 (en) 1990-12-27 1992-07-23 Abbott Laboratories N-protected aminoalkylaldehydes
EP0516409B1 (en) 1991-05-30 1996-09-11 MITSUI TOATSU CHEMICALS, Inc. Tetravinylpyrazine compound, method for preparing same and electroluminescent element and non-linear optical material using same
US5212188A (en) 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
IL107184A (en) 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5852041A (en) 1993-04-07 1998-12-22 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acethylcholine receptors
IT1274018B (it) 1994-02-23 1997-07-14 Riace Ets Derivati del 3,8-diazabiciclo(3.2.1.)ottano ad attivita' analgesica
CA2192975C (en) 1994-06-14 1999-09-21 Anton F. Fliri Benzimidazolone derivatives
GB2295387A (en) 1994-11-23 1996-05-29 Glaxo Inc Quinazoline antagonists of alpha 1c adrenergic receptors
US5604231A (en) 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5616707A (en) 1995-01-06 1997-04-01 Crooks; Peter A. Compounds which are useful for prevention and treatment of central nervous system disorders
US5597919A (en) 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5585388A (en) 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5583140A (en) 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
IL118279A (en) 1995-06-07 2006-10-05 Abbott Lab Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
US5616716A (en) 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
AU727976B2 (en) 1996-04-23 2001-01-04 Targacept, Inc. Pharmaceutical compositions for prevention and treatment of central nervous system disorders
US6979695B2 (en) * 1996-04-23 2005-12-27 Targacept, Inc. Compounds capable of activating cholinergic receptors
US20020052497A1 (en) 2000-03-09 2002-05-02 Targacept, Inc. Compounds capable of activating cholinergic receptors
US5811442A (en) 1997-02-21 1998-09-22 Bencherif; Merouane Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
US5861423A (en) 1997-02-21 1999-01-19 Caldwell; William Scott Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
CZ299499B6 (cs) 1997-10-27 2008-08-13 Neurosearch A/S Homopiperazinový derivát, farmaceutická kompoziceho obsahující a jeho použití
US6632823B1 (en) 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
KR100593433B1 (ko) * 1998-06-16 2006-06-28 타가셉트 인코포레이티드 아릴 치환된 올레핀계 아민 및 콜린성 수용체 작용제로서의 그들의 용도
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US6337351B1 (en) 1998-10-22 2002-01-08 Targacept, Inc. Pharmaceutical compositions and methods for use
FR2788982B1 (fr) 1999-02-02 2002-08-02 Synthelabo Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
WO2000075110A1 (en) 1999-06-07 2000-12-14 Targacept, Inc. Pharmaceutical compositions and methods for use
GB9922271D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Formulation
US6506769B2 (en) 1999-10-06 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
JP2003531123A (ja) 2000-04-13 2003-10-21 イノバータ・バイオミッド・リミテッド 医薬品
US6432954B1 (en) 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US6743812B1 (en) 2000-07-14 2004-06-01 Targacept, Inc. Pharmaceutical compositions and methods for use
US20020165240A1 (en) 2001-03-29 2002-11-07 Kimball Spencer David Method of treating proliferative diseases using Eg5 inhibitors
GB2381750A (en) 2001-10-10 2003-05-14 Inspire Pharmaceuticals Inc Treatment for enhancing joint lubrication
EP1463481A4 (en) 2001-12-14 2008-06-25 Targacept Inc METHODS AND COMPOSITIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
WO2003082205A2 (en) 2002-03-27 2003-10-09 Smithkline Beecham Corporation Compounds and methods
US20040044023A1 (en) 2002-08-30 2004-03-04 Marc Cantillon Compositions and methods for treating or preventing memory impairment
US20050203130A1 (en) 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US20050171088A1 (en) 2004-01-30 2005-08-04 Astrazeneca Ab Treatment of psychoses with dibenzothiazepine antipsychotic
AU2004319105A1 (en) 2004-03-29 2005-11-10 Mediquest Therapeutics, Inc. Polyamine analogs that activate antizyme frameshifting
WO2006015299A2 (en) 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
CA2580329C (en) 2004-09-13 2015-01-06 Chrono Therapeutics Inc. Biosynchronous transdermal drug delivery
UA88792C2 (ru) 2004-11-10 2009-11-25 Таргасепт, Інк. Гидроксибензоатные соли метаникотиновых соединений
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
ATE477253T1 (de) 2005-04-26 2010-08-15 Neurosearch As Neuartige oxadiazol-derivate und deren medizinische verwendung
EP2021325A2 (en) 2006-05-09 2009-02-11 AstraZeneca AB Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
TWI389889B (zh) 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
EP2032149A4 (en) 2006-06-13 2010-09-01 Fmc Biopolymer As METHOD AND SYSTEMS FOR THE USE OF BIOPOLYMER-BASED BEADS AND HYDROGELS
US20080085888A1 (en) 2006-09-15 2008-04-10 Breining Scott R Therapeutic Combinations
US20080167286A1 (en) 2006-12-12 2008-07-10 Abbott Laboratories Pharmaceutical compositions and their methods of use

Also Published As

Publication number Publication date
AU2011256866A1 (en) 2012-12-20
CA2799650A1 (en) 2011-11-24
MX2012013193A (es) 2012-12-17
KR20130081221A (ko) 2013-07-16
IL222940A0 (en) 2012-12-31
BR112012029326A2 (pt) 2017-08-08
US20130225827A1 (en) 2013-08-29
TW201213287A (en) 2012-04-01
RU2012150449A (ru) 2014-06-27
CN103180277A (zh) 2013-06-26
EP2574188A4 (en) 2015-09-02
SG185497A1 (en) 2012-12-28
JP2013528601A (ja) 2013-07-11
AU2011256866B2 (en) 2014-05-22
US8703802B2 (en) 2014-04-22
EP2574188A1 (en) 2013-04-03
WO2011146009A8 (en) 2012-01-19
WO2011146009A1 (en) 2011-11-24

Similar Documents

Publication Publication Date Title
EA201890450A1 (ru) Циклические динуклеотидные соединения в качестве агонистов sting
UA116809C2 (uk) Застосування агрохімічних сумішей для збільшення життєздатності рослини
IN2014MN02106A (es)
MX2014001605A (es) Proceso para la preparacion de compuestos de cloruro de 1h - pirazol - 5 - carbonilo n - sustituidos.
AR085155A1 (es) Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen dichos compuestos
WO2010146172A3 (en) New synthetic route for the preparation of alpha-amino boronic esters
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
EA201500320A1 (ru) Композиция (варианты) и раствор для очищения толстой кишки, лекарственное средство, набор и способ очищения толстой кишки (варианты)
EA201490569A1 (ru) Полиморфная форма гидрохлорида придопидина
RU2015119517A (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
MX2013000295A (es) Procedimiento de preparacion de un inhibidor especifico de la trombina.
EA201291370A1 (ru) Способ получения плеуромутилинов
WO2016089758A3 (en) Organo-1-oxa-4-azonium cyclohexane compounds
CO6700138A1 (es) Procedimiento de preparación de sal de l-arginina de perindoprilo
MX343950B (es) Preparacion para colonoscopia.
AR105774A1 (es) Procedimiento para la preparación de (4s)-4-(4-ciano-2-metoxifenilo)-5-etoxi-2,8-dimetilo-1,4-dihidro-1,6-naftiridina-3-carboxamida y su purificación para su uso como principio activo farmacéutico
DE502006002531D1 (de) Verfahren zum herstellen von 5-fluor-1,3-dialkyl-1h-pyrazol-4-carbonsäurefluoriden
BR112015028740A2 (pt) processo para preparar dicarbamatos de 1,4:3,6-dianidroexitóis, composto químico precursor, composto químico derivado a partir de pelo menos um dos compostos químicos precursores, e, método de preparação de um composto químico derivado a partir de pelo menos um dos compostos químicos precursores
AR081405A1 (es) Proceso para la preparacion de aminas olefinicas sustituidas con arilo o heteroarilo e intermediarios de las mismas
TN2014000329A1 (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
PE20090824A1 (es) Proceso para la preparacion de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterociclicas
MX2013012771A (es) Proceso para la preparacion de inhibidores del virus de la hepatitis c.
UA115646C2 (uk) Способи і композиції для видалення домішок з органічної солі, навантаженої домішками
CN106687441A8 (zh) 用于将第一化合物偶合到第二化合物的方法
BR112013026747A2 (pt) processo e aparelho

Legal Events

Date Code Title Description
FA Abandonment or withdrawal